Hikma Set to Enter Oncology Market with Acquisition of ribosepharm
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 81 (Table of Contents)
Published: 7 Mar-2007
DOI: 10.3833/pdr.v2007.i81.381 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Hikma Pharmaceuticals agreed to acquire the entire issued share capital of ribosepharm from ratiopharm for about US$45 M in cash...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS